I will enjoy calling you, and several others, out once this all plays out. The molecule LL will prove to be an extremely valuable asset, at the end of the day. Not defending the company and it's activities.
So are you denying the fact that 71.7% of the resubmitted BLA that received RTF letters were approved after being resubmitted? If you're not disputing that fact then it would mean that CYDY has over a 7 out of 10 chance at being approved when they resubmit. Those are favorable odds.